NKTR icon

Nektar Therapeutics
NKTR

Overview Fund Activity

199 hedge funds and large institutions have $1.78B invested in Nektar Therapeutics in 2016 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 101 increasing their positions, 34 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
199
Holders Change
+5
Holders Change %
+2.58%
% of All Funds
4.98%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
37
Increased
101
Reduced
34
Closed
28
Calls
$8.73M
Puts
$7M
Net Calls
+$1.73M
Net Calls Change
+$3.03M

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$35.2M
2
CCM
Camber Capital Management
Massachusetts
+$34.4M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$18.7M
4
Primecap Management
Primecap Management
California
+$17.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$17M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$63M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$16.8M
3
DFO
Duquesne Family Office
New York
-$9.83M
4
PC
PointState Capital
New York
-$9.45M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.37M
Name Holding Trade Value Shares
Change 		Shares
Change %
GT
226
Glenmede Trust
Pennsylvania
– -$1K -4 Closed
6 7 8 9
10